SIN 14
SIN 14, a derivative of Sinomenine (HY-15122), is an orally active HO-1 activator (KD = 17.2 μM). SIN 14 binds to the catalytic core domain of HO-1 and induces HO-1 activation in catalysis. SIN 14 significantly increases HO-1 stability. SIN 14 has anti-inflammatory effects and inhibits M1 macrophage polarization while promoting M2 polarization in LPS (Lipopolysaccharides)(HY-D1056)-induced RAW264.7 cells. SIN 14 inhibits inflammatory mediator production (eg: NO, IL-6, IL-1β and CCL2, inhibits production of ROS and down-regulates the expression of COX-2 and iNOS. SIN 14 can inhibit RA-related inflammatory edema in collagen-induced arthritis (ClA) mice.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3064262-80-9
- Formel: C19H18ClNO4
- Molecular Weight:359.80
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
HO-1 17.2 μM (Kd) |
iNOS |
COX-2 |
IL-6 |
IL-1β |
In Vitro
SIN 14 (2.5-10 μM, 24 h) can inhibit NO release in LPS-induced RAW 264.7 (IC50 = 4.97 μM), BMDM (IC50 = 3.88 μM), and BV-2 cells (IC50 = 3.88 μM)[1].
SIN 14 (2.5-10 μM, 24 h) significantly suppresses the release of inflammatory factors, including NO, IL-6, IL-1β, and CCL2, and down-regulates the expression of COX-2 and iNOS upon LPS-induced RAW 264.7 cells[1].
SIN 14 (50 μM) inhibits inflammatory cells migration and aggregation induced by CuSO4 in Tg (zlyz: EGFP) transgenic zebrafish line[1].
SIN 14 (10 μM, 24 h) inhibits M1 macrophage polarization while promoting M2 polarization in LPS-induced RAW264.7 cells[1].
SIN 14 (10 μM, 4 h or 20 min) significantly increases HO-1 stability (4 h) and enhances HO-1 resistance to pronase-induced proteolysis (20 min)[1].
SIN 14 (2.5-10 μM, 24 h) can inhibit NO production and TNF-α release, and these effects were reduced in HO-1 siRNA-transfected cells[1].
SIN 14 (10 μM, 24 h) inhibits ROS levels in LPS-induced RAW 264.7 cells by activating HO-1 (detected with the DCFH-DA probe (HY-D0940))[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:LPS induced-RAW 264.7 cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Significantly inhibited CXCL10 release and enhanced the expression of IL-10, inhibited M1 macrophage polarization.
-
Cell Line:LPS induced-RAW 264.7 cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Enhanced the expression of CD206, Arg-1, promoted M2 polarization
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male DBA/1 mice, 7-8 weeks old, weighing 18-20 g, were injected with bovine type II collagen and Complete Freund's Adjuvant (CFA)(HY-153808). 21 days later, they were boosted with bovine type II collagen and Incomplete Freund's Adjuvant (IFA)(HY-153808A) for 16 days of induction[1].
-
Dosage:10 mg/kg, 50 mg/kg
-
Administration:p.o., once daily for 36 days
-
Result:Alleviated joint swelling in both the forelimbs and hindlimbs.
Showed significant improvements in BV/TV, BMD and Tb.Th, showed notable reduction in Tb.Sp.
Decreased cartilage and bone damage as well as reduced pannus formation.
Effectively curbed the abnormal proliferation of synovial cells and alleviated damage to both cartilage and bone.
The mean paw area was markedly restored compared to the model mice.
Significantly decreased the number of TRAP-positive cells in the ankle joints compared to the CIA group, indicating the inhibitory effect on RA-related osteoclast differentiation.
Decreased 8-OHdG expression in the joint tissues.
Chemical Information
-
CAS. Nr. 3064262-80-9
-
Molecular Weight 359.80
-
Formel C19H18ClNO4
-
SMILES
O=C1OC2=C(C3=CC=C2OC)[C@]([C@@]4([H])[C@@H]5C3)(CCN5C)C1=C(Cl)C(C4)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Collagen-Induced Arthritis
Collagen-induced arthritis (CIA) is an autoimmune murine model of rheumatoid arthritis in which immunization with type II collagen (CII) emulsified in an adjuvant induces a T cell- and autoantibody-driven inflammatory arthritis characterized by synovial hyperplasia, immune cell infiltration, and joint destruction. The model typically relies on genetically susceptible mouse strains (e. g. , DBA/1) and reproduces key features of human rheumatoid arthritis, including anti-collagen immune responses and progressive joint inflammation. Disease onset generally occurs within ~3-4 weeks after immunization, depending on antigen/adjuvant combinations and protocol variation. The immunopathology is driven by adaptive immune activation against CII, leading to systemic and local joint inflammation mediated by pro-inflammatory cytokines and effector immune cells, making CIA a standard preclinical platform for evaluating immunomodulatory and anti-arthritic interventions.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Carrageenan-Induced Paw Edema
Carrageenan-induced paw edema is an acute inflammation model in which intraplantar injection of carrageenan induces localized inflammatory swelling characterized by vascular permeability, leukocyte infiltration, and production of inflammatory mediators such as prostaglandins and cytokines, making it widely used to evaluate anti-inflammatory agents in vivo. The resulting paw volume or thickness increase is quantified over time as a direct readout of inflammatory intensity and drug efficacy, typically reflecting cyclooxygenase-mediated prostaglandin-driven edema formation and immune cell recruitment in peripheral tissue[20].
-
Primary monocyte-to-macrophage differentiation
Primary human monocytes can be differentiated ex vivo into monocyte-derived macrophages by culturing purified blood monocytes for approximately 5-7 days in macrophage-supporting cytokine conditions; M-CSF commonly yields CD14^high/CD163^high macrophages, while GM-CSF yields a phenotypically distinct macrophage population, so the cytokine condition should be chosen according to the downstream model. The readout of successful differentiation is a combined change in morphology, adherence, surface phenotype, and function: differentiated macrophages become adherent, enlarge, acquire macrophage-associated markers such as CD14, CD68, CD163, CD206, or HLA-DR depending on culture condition, and show increased phagocytic capacity compared with starting monocytes.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)